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Olson: Understanding Intraoperative Crystallization 
Purpose: To report a physician survey, laboratory studies and clinical observations of 
intraoperative crystallization on the surface of the intraocular lens (IOL). 
Method: We sent a survey to all ophthalmologists in the states of Wyoming, Idaho, Montana, 
Utah and Colorado asking whether crystallization on the IOL surface had occurred in 
any of their patients and what viscoelastics, IOLs, and other solutions were used. All 
returned surveys were tabulated and analyzed by standard statistical means. A 
sample of crystallization from an IOL on a glass slide submitted by a physician was 
analyzed to ascertain the relative elemental composition. During in vitro laboratory 
studies BSS Plus (Alcon Surgical Inc., Fort Worth, Texas) and BSS (Alcon Surgical 
Inc.) were measured and analyzed for precipitation. Healon GV (PharmaciaJUpjohn, 
Inc., Kalamazoo, Michigan) and CaCh were combined in various solutions and 
examined for precipitate formation. Silicone IOLs and plate silicone were placed in 
different BSS and BSS Plus solutions with different viscoelastics and varying calcium 
concentrations. In seven patients, significant crystallization on an IOL surface was 
examined, photographed and followed for up to 3 years. 
Results: Two hundred six surveyed ophthalmologists returned 181 (88%) surveys and reported 
29,609 cataract surgeries with intraocular lens implantation with 22 (0.07%) eyes (22 
patients) in which intraoperative crystallization was observed on the intraocular lens 
surface during 1993. The survey indicated there was a correlation with BSS Plus (X2 
= 4.9, P = 0.0268) and silicone intraocular lenses (X2 = 6.8, P = 0.0093). The sample 
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Conclusion: Crystallization on the intraocular lens surface during cataract surgery is a rare 
occurrence that may be associated with calcium as the cation related to an osmotic 
gradient around the IOL with increased calcium concentration. If encountered 
surgically, the lens should be exchanged in the operating theater after irrigating the 
anterior chamber with BSS and completely filling the capsular bag with a low 
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Intraoperative crystallization on the surface of the intraocular lens (lOL) implant is a 
dramatic event. Diffuse crystals can suddenly appear on the intraocular lens (IOL) surface, 
immediately after insertion. This phenomenon has been previously reported, 1 but its incidence, 
etiology and prevention are unknown. 
After four years of investigation, we report a physician survey, laboratory studies and 
clinical observations of intraoperative crystallization on the surface of the intraocular lens. 
METHODS 
A survey was sent to all ophthalmologists in the states of Wyoming, Idaho, Montana, 
Utah and Colorado. A clinical picture of a patient with crystallization on the IOL surface was 
included with the survey (Fig 1) and questions about whether this condition was seen, number of 
cataract cases performed, percentage of silicone or polymethylmethacrylate (PMMA) IOLs used, 
and percentage of viscoelastics and BSS (Alcon Surgical Inc., Fort Worth, Texas) or BSS Plus 
(Alcon Surgical Inc.) if used, for all of the cases performed in 1993. All returned surveys were 
tabulated and analyzed by standard statistical means. 
One doctor in the survey submitted a sample of crystallization from an IOL on a glass 
slide. This specimen was cut in thirds by microdissection with one part analyzed by x-ray 
photoelectron spectroscopy for elemental identification. The remaining two parts were analyzed 
by scanning electron microscopy (SEM) and x-ray fluorescence to ascertain the relative 
elemental composition. 
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1) BSS Plus pH stability was measured in a beaker at room temperature for fifty hours. 
Measurements were made every 2 hours for four measurements and then occasionally 
throughout the 50-hour period. The pH stability over the entire 50 hours showed no 
significant drift and stayed at a value of 7.45, plus or minus 0.01, during the entire time 
for BSS Plus. 
2) An analysis for precipitation of BSS Plus was performed with reconstituted BSS Plus at 
room temperature. A Brookhaven BI200 particle sizer with a 30 mW helium-neon laser 
light source was used to detect precipitates in the solution. The detection limit was 1.0 
mg/ml for very small proteins. The solution was analyzed every 2 hours for 24 hours, 
then twice a day for 2 more days, for a total of 72 hours. Precipitation in BSS Plus was 
not noted for the entire period, 
3) Five hundred microliter samples of Healon GV (PharmacialUpjohn, Inc., Kalamazoo, 
Michigan) were combined with a sample of 50!1L of 5.0 mM CaCh, 100!1L of 5.0 mM 
CaCh, 200!1L of 5.0 mM CaCh and 500!1L of CaCho These solutions were examined 
for precipitate formation. No precipitate was seen with the addition of 50-500 !11 aliquots 
of 5.0 mM CaCh to 0.5 m1 of Healon GV. 
4) On top of 500 !1L of Healon GV, a 200 !1L solution of blue Dextran (by Pharmacia, 
molecular weight of 2 x 106 gmlmol) was placed. The resulting diphasic solution was 
observed for any fluid shifts. The layering visibly demonstrated the rapid concentration 
of blue polymer in the ever-shrinking volume of superphase above the hyaluronic phase. 
There was obviously an osmotic gradient pulling water into the hyaluronate and 
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5) Solutions of BSS and BSS Plus had CaCh added in increasing concentrations until the 
calcium concentration was 20 mM. The solution was measured by UV absorbence at 254 
nm to measure for precipitation. BSS+ was measured just after mixing, 5 and 15 minutes 
later. BSS and BSS Plus respond very differently to the addition of CaCh as measured 
by UV absorbance at 254 nm. Through 20 mM CaCh concentration BSS remained clear 
at all times, while BSS Plus showed increasing precipitation, especially after 3.0 mM 
CaCh solution. 
6) BSS and BSS Plus were mixed in a one-to-one ratio and measured by 254 nm UV 
absorbence for 24 hours for evidence of precipitation. A one-to-one mixture examined 
for 24 hours did not show any precipitation. 
7) A STAAR plate silicone IOL (STAAR Surgical Company, Monrovia, CA) and an AMO 
SI-30 silicone IOL (Allergan Medical Optics, Irvine, CA) were each placed in a BSS Plus 
solution for 24 hours. The IOLs were then removed and examined by SEM for any 
crystallization on the surface of the lenses. There was no crystallization on the IOL 
surface. 
8) A STAAR plate silicone IOL and an AMO SI-30 silicone IOL were each introduced into 
equal volumes of BSS Plus and Healon GV for 24 hours. These lenses were then 
removed and examined by SEM for any crystallization on the IOL surface. Silicone IOLs 
did not reveal any evidence of crystallization. 
9) Two sets of each of the following were thoroughly mixed: 
1. 0.5 ml BSS Plus plus 0.2 ml Healon GV. 
2. 0.5 ml BSS Plus plus 0.2 ml Amvisc. 
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Silicone ingots were washed with isopropanol, ethanol and distilled water, blot dried on 
filter paper, and placed in each of the six solutions. Calcium chloride was added to the 
solutions to vary the concentrations from 3.6 up to 14.4 mM of calcium by addition of 
CaCho The silicone ingots were then examined visually for crystallization. A mixture of 
0.5 ml of BSS Plus and 0.2 ml of Healon GV with a silicone ingot and additions of CaCh 
did show a clear correlation with calcium ion content with those cells containing 7.2 mM 
calcium ion or above showing solution precipitates, while the surface of the silicone 
ingots remained clear to visual examination in all cases. In the presence of 3.6 mM 
calcium ion, the IOLs and solution remained clear for several hours; however, the 
solution turned cloudy overnight with no specific IOL deposit by visual examination 
accumulating on the silicone surface. For this experiment the Healon GV and BSS Plus 
were mixed to produce a homogeneous solution for placement of the silicone ingots so 
there was no superphase. 
10) Fura-2 (CaIBiochem, MW 751), a calcium binding fluorescence probe,2 was mixed (1.0 
mg) in 1.33 !1L DMSO then diluted with distilled water to yield 10 !1M solution. A 
standard curve was measured under dual excitation (340 and 380 nm) at fixed emission 
510 nm using a Perkin-Elmer LB50 fluorometer. The solution showed a linear excitation 
curve up to 2.5 mM calcium with minimal changes in excitation after that up through a 
15.0 mM calcium chloride solution. 
11) Healon GV (0.85 ml), Healon (0.85 ml), Amvisc Plus (0.8 ml, Amvisc (0.8 ml) and 
Occucoat (1.0 ml) were added to triple washed glass cells. One hundred microliters (plus 
1.0 !11 of Fura-2 stock solution from experiment 10) of BSS Plus were added to the top 
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Healon GV only. Two microliter samples of the liquid phase on top were removed for 
calcium analysis by fluorescence as outlined in experiment 10 immediately after,S 
minutes and 15 minutes later. The BSS and BSS Plus solutions were rapidly absorbed 
into the viscoelastic so sampling the fluid superphase was difficult. By the time the 
pipette was introduced, there was a minimal liquid phase. Initial results did show the 
highest concentration of calcium in BSS Plus with Healon GV (3.25 mM) and the lowest 
with Amvisc Plus (1.0 mM); however, these differences were not statistically significant. 
Sampling at 5 and 15 minutes was of the viscoelastic with no fluid phase evident, and 
there were no differences noted with time. 
12) Healon GV (0.85 ml) was placed in a triple washed glass cell. BSS Plus solution (0.5 
ml) to which was added CaCh to bring the calcium concentration to 7.2 mM was placed 
on top of the viscoelastic and an IOL added to the liquid phase. This was repeated for 
two silicone and two PMMA IOLs. After 15 minutes the IOLs were removed and 
examined by SEM with x-ray fluorescence to ascertain the relative elemental 
composition of any deposits. Light microscopic photos of all four IOLs revealed 
characteristic deposits not evident by unmagnified visual inspection. Deposits on the 
PMMA IOLs were typical feathery crystals similar in appearance to Fig 2. Deposits on 
the silicone IOLs were distinctive circular rings with some feathery irregularities also 
noted. These changes were consistent throughout the samples (Fig 3). Elemental 
analysis showed significant calcium only in the crystals themselves. Analysis of the 
PMMA lenses were difficult due to material melting so this observation was only definite 
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Seven patients (seven eyes) with significant crystallization on an IOL surface using 
Healon GV with silicone IOLs in uncomplicated surgery were examined and photographed. 
These patients have previously been described and were followed for up to three years to obtain a 
natural history of this process. 
RESULTS 
Of the 206 surveys sent to ophthalmologists in the Rocky Mountain States, 181 surveys 
(88%) were completed (29,609 surgeries) and sent back to us for analysis. A total of 22 (0.07%) 
eyes (22 patients) of intraoperative crystallization were reported. Statistical analysis shows that 
there is a statistically significantly increased incidence of crystallization associated with the use 
of BSS Plus (X2 = 4.9, P = 0.0268) and silicone IOLs (X2 = 6.8, P = 0.0093). Although 50% of 
the cases were associated with Healon GV and Healon GV was used in only 8.1 % of all cases, 
statistical analysis of such small samplings is not statistically valid. Word of our interest in this 
project prompted one physician outside the area to submit information for the same year. This 
physician had three cases of precipitation at the time of surgery. 
SEM of the submitted clinical specimen showed a unique form of feathery crystal (Fig 2). 
Contiguous features were typically 10 /-lm or less in width with multiple such features arranged 
c C in a leaf-like fashion. X-ray fluorescence performed on both SEM specimens showed virtual 
~ 
~ > coincidence of the analytical results in anatomic percent. The five most abundant elements 
C 
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The specimen submitted for x-ray photoelectron spectroscopy using a Hewlett Packard 
5950B spectrometer indicated presence of the following major components: sodium (12%), 
silicone (7.6%), carbon (42%), calcium (1 %), nitrogen (0.4%), and oxygen (37%). The 
composition is quantified in an atomic percent of elements. 
Because of the large number of in vitro tests performed, the results of each test were 
reported after the description of the test procedure in the Methods section. 
The seven patients (seven eyes) with silicone lenses and significant crystalline deposits 
had varying degrees of symptoms as can be seen in Table 1 with clinical details previously 
described. l While two patients had macular degeneration, decreased vision to 20/40 from the 
deposits was felt to be documented in the absence of any other cause for decreased vision in at 
least two patients. While the majority cleared spontaneously, three years later some 
crystallization sequestered between the capsule and the lens has remained without decrease or 
change. In the one patient with 20/40 vision without additional pathology due to the lack of 
resolution of the crystals, a Nd:YAG capsulotomy was carried out with difficulty. The crystals 
seemed to concentrate the energy once the capsule was cut and resulted in a significant mark in 
the intraocular lens. Keeping away from the optical center, however, a posterior capsular 























Olson: Understanding Intraoperative Crystallization 
The event of crystallization at the time of surgery is exceedingly uncommon; however, 
we have documented that it can be clinically significant and very persistent. It is important to 
remember that with an overall incidence of less than one in 1,000 cases, five ophthalmologists 
had two or more cases, usually closely grouped. One had three cases in the same day! On 
survey, the vast majority of ophthalmologists had never seen this phenomenon. 
The clinical survey suggested an incidence of approximately one in 1,400 cases. The 
actual incidence is probably much lower. It is important to understand that our 12 cases 
(includes five additional cases on PMMA) and three cases from an outside ophthalmologist 
represent 15 of the total for just three surgeons and probably skews the incidence higher than it 
really is. We believe the true incidence is probably less than in one in 10,000 and explains why 
so many ophthalmologists have never encountered this phenomenon. The survey does help to 
correlate this finding with surgical variants, particularly BSS Plus and silicone intraocular lenses. 
While statistical analysis of any viscoelastic association is necessarily difficult to assess, it is 
known that 50% of cases occurred with Healon GV while Healon GV was used in only 8.1 % of 
the cases. 
Healon GV was identified early as a likely cause of crystallization since all of the 
original cases occurred when this product was used. 1 The overall incidence with Healon GV was 
11 cases out of 278 ( 4%) cataract extractions. The theory, that crystallization was associated 
only when Healon GV was used, changed when an additional case occurred with the use of 
Amvisc Plus (Chiron Vision Corporation, Claremont, California). It was further discovered that 
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Company, Pearl River, NY) and other viscoelastics as well. Healon GV remained a concern but 
was not considered to be the sole cause. 
Correlation with silicone appeared to be strong with no cases of significance having been 
noted on PMMA. Five instances of precipitation on PMMA were so minimal that it was only 
visible to two experienced viewers who had seen previous silicone IOL crystallization. Probably 
this finding would be missed by most observers. Silicone appears to be a substrate that is more 
sensitive to extensive crystallization. 
BSS Plus is related to this phenomenon by statistical analysis. Although the calcium 
concentration of BSS Plus reconstituted is significantly lower than BSS (1.0 vs. 3.25 mM) the 
citrate in BSS allows this solution to accommodate calcium ion in excess of 20 mM without 
showing signs of turbidity. BSS Plus, on the other hand, shows an increase in turbidity with 
concentrations above 3.5 mM which drastically increases when above 7.0 mM. In fact, it is hard 
to understand how this phenomenon could occur with BSS plain due to the citrate component. 
The specimen was extremely serendipitous, but we recognize, however, that this is not 
our typical case. The crystallization that we have seen does not come off of the lens surface 
either by irrigation or by instrumentation. It is gritty and exceedingly adherent to the intraocular 
lens surface. The actual crystalline component of this star-fish-shaped specimen is similar in 
appearance although it appears to have occurred in a different matrix (probably fibrin). The 
specimen suggests that calcium is the cation of concern. This is corroborated by our in vitro 
recreation of the clinical situation in experiment 12. The similarities of these crystals and the 
crystals in this experiment also suggest that this case is probably related. 
It should be pointed out that the discrepancy in relative atomic percentages is most likely 
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spectroscopy is based on a collected signal from a 5.0 mm2 surface area while the scanning 
electron microscopy x-ray fluorescence analysis was collected from an area of approximately 
250/lm.2 In addition to spot size, the two analyses probe different depths with x-ray 
photoelectron spectroscopy sampling the uppermost 50 A while x-ray fluorescence samples 
significantly deeper layers. Thus, while the sensitivity of the SEM techniques is lower, it has the 
advantage of reporting the composition of specific features of interest which in this case are the 
crystals themselves. Both techniques report the presence of silicone as is expected from the 
glass mount. We don't feel that silicone is any part of the actual crystallization. The high 
content of sodium is also partially contributed by the glass substrate, but must in part stem from 
the deposit. The small amount of nitrogen with a carbon-to-nitrogen ratio of 100 to 1 is much 
lower than what is typically observed on protein containing surfaces and, therefore, allows us to 
rule out the possibility that the precipitate is primarily protein. Although we feel the elemental 
analysis at least shows us that the cation of concern is calcium, it really gives us no clear clue as 
to the anion except to be able to exclude phosphorus-containing compounds. 
In vitro analysis was a series of steps that gave a fairly clear picture of what occurred. It 
is reassuring to know that either BSS Plus and/or BSS Plus with Healon GV alone would not 
result in precipitation with or without a silicone IOL. The addition of blue Dextran, however, 
did reveal the possibility of an osmotic gradient in a diphasic solution drawing water into the 
viscoelastic and concentrating the solutes in the liquid nonhyaluronic phase. We also were able 
to show that precipitation on both PMMA and silicone surfaces consistently occurred at a 7.2-
mM calcium concentration. The deposits were different when looking at PMMA and silicone 
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Our theory is that viscoelastics produce an osmotic gradient with Healon GV creating the 
greatest colloidal pressure. With an anterior chamber filled with a viscoelastic, the IOL makes 
its way into the capsule and into a liquid phase with solutes rapidly concentrating. Due to the 
osmotic gradient, abnormal concentrations of calcium can rarely occur under these 
circumstances resulting in precipitation on the IOL surface. Subclinical deposits may be very 
common. Due to the citrate present in BSS, such precipitation could only occur at very high 
calcium concentrations or possibly where there is minimal to no BSS and only normal calcium 
containing aqueous sequestered in the capsular remnant. What is clear to us is BSS would be 
very resistant to this phenomenon. The third part of the equation is that the silicone substrate 
lends itself to the diffuse and clinically significant crystallization as has been seen in patients. 
The work by Shumakov et als suggests in vitro that silicone was more sensitive to calcification 
than polyurethane and polyethylene.s While not directly related, we feel this work on 
biomaterial calcification is supportive of our thesis. 
This theory appears to explain our observed correlations from the survey and just how the 
phenomenon may occur. It doesn't explain the one case reported to us from our survey with 
unusual crystallization immediately after intracameral acetylcholine solution irrigation. We did 
not include this case in our results due to the diffuse crystallization which resolved in 10 days. 
We have not heard of nor can find a similar case in the literature and report this here for 
completeness sake. 
Calcification of the superficial corneal stroma associated with an older preparation of 
Viscoat (Alcon Surgical Inc., Fort Worth, Texas) and dystrophic calcification of silicone scleral 
buckling implant materials have been well documented in the literature,3,4,6 but what we have 
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Unusual crystalline material discovered within a PMMA posterior chamber lens with 
polypropylene haptics seven to eight years after implantation,7 is unrelated to the phenomenon 
we describe. It is also not related to PMMA intracomeal implants which have shown a 
crystalline aggregate in the deep corneal stroma behind the implant. 8,9 
In summary, we have described crystallization on IOLs with calcium as the cation that 
we feel is related to an osmotic gradient created by the viscoelastic resulting in increased 
calcium concentration (usually with BSS Plus) resulting in precipitation and crystallization on 
the surface of silicone lenses in all clinically significant cases. 
RECOMMENDATIONS FOR MANAGEMENT 
Intraoperative crystallization on an IOL is rare: however, one surgeon encountered three 
cases in one day. Generally, crystals on the intraocular lens cannot be removed. We would 
remove such an IOL immediately, fill the posterior chamber with plain BSS followed by a 
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A clinical slit lamp photo of a 82 year old male, 8 months after surgery with 
moderate and typical crystallization (arrow) on a silicone IOL. 
Scanning electron microscopy (SEM) of crystalline deposits peeled from an IOL 
at surgery. Top photo at 490X shows a feathery pattern to the crystals. 
Bottom photo shows the same crystals at 6800X. 
Scanning electron microscopy at 100X of deposits created in vitro on a PMMA 
IOL (top) and a silicone IOL (bottom). Characteristic deposits 
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Table 1: Summary of patient severity, visual acuity and most recent outcome of crystalline precipitates on silicone IOLs. 
Patient # Age Sex Eye Description of Impact on Visual Length of Clinical course of crystallization 
Severity* Acuity Follow-up 
1 76 F aD +1 20/20 6/8/93-5/8/96 Cleared with a few sequestered crystals. Not clinically 
None (35 months) significant 
20/20 last exam 
2 83 F as +2 20/40 Best at first. 7/6/93 - 10/18/95 Cleared with a few sequestered crystals. 
Improved to 20/20 (27 months) 
3 50 M as +1 None (20/20 at last 8/10/93 - 8/1/96 Deposits sequestered by capsule still present 
exam) (36 months) 
4 82 F as +3 20/60 before laser 8/18/93 - 2/8/94 Central clearing after a difficult laser capsulotomy. Visual 
caps ulotomy (6 months) acuity when last seen was 20/30. No other pathology that 
20/30 after could decrease vision was noted. 
5 81 M as +3 20/100 8/18/93 - 11/8/94 CF advanced macular degeneration at last exam. No 
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6 84 F OS +1 20/25 at 3-month 9/8/93 - 8/6/96 Not ever clinically significant and had cleared with early 
postop. 20/40 last (35 months) macular degeneration noted at last exam. 
exam. 
7 87 F OS +2 Blurred vision, 2+ 10/13/93-5/14/96, Edemalblurred vision first postoperative day. At 3-week 
central corneal 32 months. visit, visual acuity was 20/30, later improving to 20/20. 1+ 
edema, 20/200 crystals last seen 1110/95 (15 months postop). 
* Severity description was determined by examination of the photographs taken for each patient on the first postoperative day. Photographs that showed the 
greatest density of crystallization were assigned a severity of +3, and photographs that showed the least density were assigned a severity of trace. A level +3 
severity would be dense/white/crystals in high concentration with central location felt to affect visual acuity. Severity of 2+ is moderately dense possibly 
affecting visual acuity still widely spread along surface oflens. A + 1 severity is scattered crystals/non-dense, not affecting visual acuity, randomly scattered 
across the lens surface and not necessarily centrally located. 
